Daws D. Ryan 4
4 · enGene Holdings Inc. · Filed Jan 31, 2025
Insider Transaction Report
Form 4
Daws D. Ryan
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-29+280,000→ 280,000 totalExercise: $7.39Exp: 2035-01-29→ Common Shares (280,000 underlying)
Footnotes (1)
- [F1]This option vests monthly in substantially equal amounts for 48 months, subject to the reporting person's continued service.